Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D3 receptor ligands

Xin Peng, Qi Wang, Yogesh Mishra, Jinbin Xu, David E. Reichert, Maninder Malik, Michelle Taylor, Robert R. Luedtke, Robert H. Mach

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


A series of 2-methoxyphenyl piperazine analogues containing a triazole ring were synthesized and their in vitro binding affinities at human dopamine D2 and D3 receptors were evaluated. Compounds 5b, 5c, 5d, and 4g, demonstrate high affinity for dopamine D3 receptors and moderate selectivity for the dopamine D3 versus D2 receptor subtypes. To further examine their potential as therapeutic agents, their intrinsic efficacy at both D2 and D3 receptors was determined using a forskolin-dependent adenylyl cyclase inhibition assay. Affinity at dopamine D4 and serotonin 5-HT1A receptors was also determined. In addition, information from previous molecular modeling studies of the binding of a panel of 163 structurally-related benzamide analogues at dopamine D2 and D3 receptors was applied to this series of compounds. The results of the modeling studies were consistent with our previous experimental data. More importantly, the modeling study results explained why the replacement of the amide linkage with the hetero-aromatic ring leads to a reduction in the affinity of these compounds at D3 receptors.

Original languageEnglish
Pages (from-to)519-523
Number of pages5
JournalBioorganic and Medicinal Chemistry Letters
Issue number3
StatePublished - 1 Feb 2015


  • Dopamine D receptor selective ligands
  • Dopamine receptors
  • Molecular modeling
  • Triazole


Dive into the research topics of 'Synthesis, pharmacological evaluation and molecular modeling studies of triazole containing dopamine D<sub>3</sub> receptor ligands'. Together they form a unique fingerprint.

Cite this